688117 ChengDu Sheng Nuo Biotec
- 28.55
- +0.33+1.17%
ChengDu Sheng Nuo Biotec News
Shengnuo Biotech: Simplified Equity Change Report (Lepu Healthcare)
Shengnuo Biotech: Notice on the Controlling Shareholder Agreement to Transfer Part of the Company\'s Shares and Complete Transfer Registration
Shengnuo Biotech: An indicative announcement on changes in the equity of shareholders holding 5% or more of the shares
Announcement on the transfer registration of part of the company\'s shares by agreement with the controlling shareholder
An indicative announcement on changes in the equity of shareholders holding 5% or more of the shares
Simplified equity change report (Lepu Healthcare)
Announcement on holding the results briefing for the third quarter of 2024
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024
Shengnuo Biotech: Announcement on increasing the amount of daily related transactions expected in 2024
Shengnuo Biopharmaceutical Co., Ltd.: Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Shengnuo Biotech: Announcement on the company increasing the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Shengnuo Biotech: Minsheng Securities Co., Ltd.\'s inspection opinion on the extension of some fund-raising investment projects of Chengdu Shengnuo Biotechnology Co., Ltd.
Shengnuo Biotech: Announcement on the extension of some fund-raising investment projects
Shengnuo Biotech: Third Quarter Report 2024
Shengnuo Biotech: Announcement of Resolutions of the 22nd Meeting of the 4th Board of Supervisors
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for a wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Notice on the company increasing the guarantee amount for wholly-owned subsidiaries to apply for comprehensive bank credit in 2024
Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024
Analysis
Price Target
No Data
No Data